Clinical Trial Update: A Clinical Trial to Assess the Safety of SOR102 in Healthy Participants and Patients With Ulcerative Colitis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial completed to assess the safety of SOR102 in healthy participants and patients with ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• SOR102

Snippet

Sponsor: Sorriso Pharmaceuticals, Inc. | Conditions: Ulcerative Colitis | Phase 1 | Status: COMPLETED